ESCAIDE 2019

On this page you will find documents and material from ESCAIDE 2019 which took place on 27-29 November in Stockholm, Sweden. These include the webcast recordings and presentations from the plenary sessions, conference and communication materials.

Video playlist

Conference pictures

Abstract

Speakers

Programme

Time

Day 1, Wednesday 27 November 2019

Day 2, Thursday 28 November 2019

Day 3, Friday 29 November 2019

8:15 -

Registration & coffee

Registration

Registration

9:00-10:30

Welcome (09:00- 09:15)

 

Plenary session A:  “Health security and preparedness: lessons from Ebola"

 

Dr. Mike Ryan, World Health Organization, Switzerland

 

Chair: Prof. Mike Catchpole (ECDC)

Plenary session C: “The microbiome: what you need to know”

 

Dr. Sean Gibbons, Institute for Systems Biology, United States of America

Prof. Debby Bogaert, The University of Edinburgh, United Kingdom

 

Chairs: Dr. João André Carriço (Medical University of Lisbon, Portugal); Dr. Christopher Barbara (Mater Dei Hospital, Malta)

Plenary session D: “How should public health research priorities be defined, and what should they be?”

Dr. Ed Whiting, Wellcome Trust, United Kingdom

Dr. Lina Moses, School of Public Health & Tropical Medicine/ Tulane University, United States of America

Dr. Jean- Claude Desenclos, IANPHI, Public Health France

 

Chairs: Dr. Maria Van Kerkhove (WHO HQ); Dr. Frode Forland (Norwegian Institute of Public Health); Amrish Baidjoe (WHO-South-East Asia Regional Office)

10:30-11:00

Refreshments

Refreshments

Refreshments

11:00-12:40

Parallel sessions

1. Emerging and vector-borne diseases: surveillance approaches

2. Vaccine-preventable diseases: vaccine coverage, safety and uptake 

3. Healthcare-associated infections: burden and prevention

Parallel sessions

7. Food- and waterborne diseases and zoonoses: public health microbiology and surveillance methods

8. Vaccine-preventable diseases: surveillance (1)

9. Influenza: vaccination and intervention (1)

Parallel sessions

16. Vaccine-preventable diseases: epidemiology

17. Hepatitis B and C: surveillance and disease burden

18. Food- and waterborne diseases and zoonoses outbreaks (2) 

12:40 -14:30

Lunch / Eurosurveillance seminar

Lunch/ EAN General Assembly meeting

Lunch/ Career compass

14:30-15:30

Parallel sessions

4. Antimicrobial resistance and healthcare-associated infections: epidemiology

5. Emerging and vector-borne diseases: epidemiology

6. Food- and waterborne diseases and zoonoses outbreaks (1)

Parallel sessions

10. Antimicrobial resistance and healthcare-associated infections: surveillance

11. Late breakers

12. Influenza: vaccination and intervention (2)

Parallel sessions

19.  Vaccine-preventable diseases surveillance (3)

20. Food- and waterborne diseases and zoonoses surveillance

21. Late breakers

15:40-16:40

Moderated poster session

1. Antimicrobial resistance 

2. Emerging and vector-borne diseases, and international health (1)

3. Food- and waterborne diseases and zoonoses (1):  outbreaks (I)

4. Food- and waterborne diseases and zoonoses (2):  surveillance

5.  Influenza and other respiratory viruses (1)

6.  HIV, sexually transmitted infections and viral hepatitis (1): surveillance and burden of disease

7.  Vaccine-preventable diseases (1): measles

8.  Vaccine-preventable diseases (2): surveillance

Moderated poster session

9. Healthcare-associated infections

10. Emerging and vector-borne diseases, and  International health (2): vector-borne diseases

11. Food- and waterborne diseases (3):   epidemiology and burden of disease

12. Food- and waterborne diseases and zoonoses (4): public health microbiology

13. HIV, sexually transmitted infections and viral hepatitis (2): intervention

14. Tuberculosis and other respiratory diseases (excluding viruses) (1): surveillance and modelling

15. Influenza and other respiratory viruses (2):  vaccination and interventions

16. Vaccine-preventable diseases (2)

Moderated poster session

17.  Food- and waterborne diseases and zoonoses (5): outbreaks (II)

18. Tuberculosis and other respiratory diseases (excluding viruses) (2): epidemiology

19. Emerging and vector-borne diseases and International health (3): surveillance approaches

20. HIV, sexually transmitted infections and viral hepatitis (III): surveillance & epidemiology

21. Influenza and other respiratory viruses (3): Human Respiratory Syncytial virus

22. Influenza and other respiratory viruses (4)

23. Vaccine-preventable diseases (4):  vaccine coverage, uptake and response

24. Late breakers

 

16:40-17:00

Refreshments

Refreshments

Refreshments

17:00-18:30

Plenary session B: “Vaccine confidence in a post-factual world”

 

Prof. Dr. Wolfgang Gaissmaier, Social Psychology and Decision Sciences, University of Konstanz

Dr. Robb Butler, WHO Regional Office for Europe

 

Chairs: Prof. Dr. Bojana Beović (University of Ljubljana Slovenia); Dr. Frantiska Hruba (ECDC). 

 

 

Parallel sessions

13. HIV and STI: prevalence and prevention

14. Respiratory disease: surveillance and modelling 

15. Vaccine-preventable diseases  surveillance (2)

Plenary session E: “Climate change: Addressing the public health challenge in Europe”

 

Dr. Henriette De Valk, Public Health France

Prof. Dr. Ana Maria de Roda Husman, National Institute for Public Health and the Environment, The Netherlands

 

Chairs: Dr Susan Hahné (National Institute for Public Health and the Environment) and Prof. Dr. Aura Timen (National Institute for Public Health and the Environment and Free University of Amsterdam)

 

Reception  (18:45- 21:00)

BarCamp (18:45- 20:00)

Closing Ceremony and EAN prizes award (18:30- 18:40)